EyeGene Inc. (KOSDAQ: 185490)
South Korea
· Delayed Price · Currency is KRW
2,730.00
-20.00 (-0.73%)
Dec 19, 2024, 9:00 AM KST
EyeGene Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 72,305 | 91,605 | 108,036 | 408,921 | 148,527 | 132,693 | |
| Market Cap Growth | 21.08% | -15.21% | -73.58% | 175.32% | 11.93% | -15.90% | |
| Enterprise Value | 41,650 | 52,919 | 41,816 | 313,462 | 127,760 | 110,766 | |
| Last Close Price | 2675.00 | 4265.00 | 5030.00 | 19100.00 | 9668.54 | 8758.56 | |
| PS Ratio | 17.58 | 29.31 | 20.41 | 126.13 | 44.16 | 31.26 | |
| PB Ratio | 1.36 | 1.42 | 1.57 | 4.60 | 11.51 | 6.97 | |
| P/TBV Ratio | 1.69 | 1.47 | 1.64 | 4.64 | 11.97 | 7.15 | |
| EV/Sales Ratio | 12.78 | 16.93 | 7.90 | 96.68 | 37.99 | 26.09 | |
| Debt / Equity Ratio | 0.07 | 0.05 | 0.03 | 0.04 | 1.33 | 0.96 | |
| Asset Turnover | 0.05 | 0.04 | 0.06 | 0.04 | 0.07 | 0.08 | |
| Inventory Turnover | 3.49 | 4.56 | 4.10 | 2.40 | 3.59 | 8.97 | |
| Quick Ratio | 5.39 | 9.23 | 13.79 | 8.99 | 3.92 | 2.33 | |
| Current Ratio | 5.55 | 9.33 | 13.99 | 9.22 | 4.25 | 2.47 | |
| Return on Equity (ROE) | -28.19% | -33.66% | -33.55% | -67.87% | -93.10% | -41.25% | |
| Return on Assets (ROA) | -13.26% | -21.36% | -16.24% | -29.28% | -18.63% | -11.54% | |
| Return on Capital (ROIC) | -15.64% | -24.38% | -18.33% | -35.59% | -25.42% | -14.13% | |
| Earnings Yield | -24.61% | -23.04% | -24.02% | -8.45% | -10.01% | -6.59% | |
| FCF Yield | -22.03% | -23.42% | -17.90% | -7.92% | -7.94% | -7.02% | |
| Buyback Yield / Dilution | 0.34% | -0.94% | -13.22% | -36.98% | -3.62% | -1.23% | |
| Total Shareholder Return | 0.34% | -0.94% | -13.22% | -36.98% | -3.62% | -1.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.